Literature DB >> 23116792

Influenza A(H1N1)pdm09-related pneumonia and other complications.

Diego Viasus1, José A Oteo Revuelta, Joaquín Martínez-Montauti, Jordi Carratalà.   

Abstract

Influenza A(H1N1)pdm09 virus infection was associated with significant morbidity, mainly among children and young adults. The majority of patients had self-limited mild-to-moderate uncomplicated disease. However, some patients developed severe illness and some died. In addition to respiratory complications, several complications due to direct and indirect effects on other body systems were associated with influenza A(H1N1)pdm09 virus infection. The main complications reported in hospitalized adults with influenza A(H1N1)pdm09 were pneumonia (primary influenza pneumonia and concomitant/secondary bacterial pneumonia), exacerbations of chronic pulmonary diseases (mainly chronic obstructive pulmonary disease and asthma), the need for intensive unit care admission (including mechanical ventilation, acute respiratory distress syndrome and septic shock), nosocomial infections and acute cardiac events. In experimentally infected animals, the level of pulmonary replication of the influenza A(H1N1)pdm09 virus was higher than that of seasonal influenza viruses. Pathological studies in autopsy specimens indicated that the influenza A(H1N1)pdm09 virus mainly targeted the lower respiratory tract, resulting in diffuse alveolar damage (edema, hyaline membranes, inflammation, and fibrosis), manifested clinically by severe acute respiratory distress syndrome with refractory hypoxemia. Influenza A(H1N1)pdm09-related pneumonia and other complications were associated with increased morbidity and mortality among hospitalized patients.
Copyright © 2012 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23116792      PMCID: PMC7130364          DOI: 10.1016/S0213-005X(12)70104-0

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  57 in total

1.  Pneumococcal pneumonia and influenza: a deadly combination.

Authors:  Keith P Klugman; Yu-Wen Chien; Shabir A Madhi
Journal:  Vaccine       Date:  2009-08-21       Impact factor: 3.641

2.  Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico.

Authors:  Rogelio Perez-Padilla; Daniela de la Rosa-Zamboni; Samuel Ponce de Leon; Mauricio Hernandez; Francisco Quiñones-Falconi; Edgar Bautista; Alejandra Ramirez-Venegas; Jorge Rojas-Serrano; Christopher E Ormsby; Ariel Corrales; Anjarath Higuera; Edgar Mondragon; Jose Angel Cordova-Villalobos
Journal:  N Engl J Med       Date:  2009-06-29       Impact factor: 91.245

3.  Changes in epidemiology, clinical features and severity of influenza A (H1N1) 2009 pneumonia in the first post-pandemic influenza season.

Authors:  D Viasus; E Cordero; J Rodríguez-Baño; J A Oteo; A Fernández-Navarro; L Ortega; I Gracia-Ahufinger; M C Fariñas; E García-Almodovar; A Payeras; J R Paño-Pardo; E Muñez-Rubio; J Carratalà
Journal:  Clin Microbiol Infect       Date:  2012-01-20       Impact factor: 8.067

4.  Electrocardiographic abnormalities in patients with novel H1N1 influenza virus infection.

Authors:  Nikolaos Akritidis; Maria Mastora; Gerasimos Baxevanos; Georgios Dimos; Georgios Pappas
Journal:  Am J Cardiol       Date:  2010-09-24       Impact factor: 2.778

5.  Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation.

Authors:  Elisa Estenssoro; Fernando G Ríos; Carlos Apezteguía; Rosa Reina; Jorge Neira; Daniel H Ceraso; Cristina Orlandi; Ricardo Valentini; Norberto Tiribelli; Matías Brizuela; Carina Balasini; Sebastián Mare; Gustavo Domeniconi; Santiago Ilutovich; Alejandro Gómez; Javiera Giuliani; Cecilia Barrios; Pascual Valdez
Journal:  Am J Respir Crit Care Med       Date:  2010-03-04       Impact factor: 21.405

6.  Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California.

Authors:  Janice K Louie; Meileen Acosta; Kathleen Winter; Cynthia Jean; Shilpa Gavali; Robert Schechter; Duc Vugia; Kathleen Harriman; Bela Matyas; Carol A Glaser; Michael C Samuel; Jon Rosenberg; John Talarico; Douglas Hatch
Journal:  JAMA       Date:  2009-11-04       Impact factor: 56.272

7.  Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study.

Authors:  G Rohde; A Wiethege; I Borg; M Kauth; T T Bauer; A Gillissen; A Bufe; G Schultze-Werninghaus
Journal:  Thorax       Date:  2003-01       Impact factor: 9.139

8.  Critically ill patients with 2009 influenza A(H1N1) infection in Canada.

Authors:  Anand Kumar; Ryan Zarychanski; Ruxandra Pinto; Deborah J Cook; John Marshall; Jacques Lacroix; Tom Stelfox; Sean Bagshaw; Karen Choong; Francois Lamontagne; Alexis F Turgeon; Stephen Lapinsky; Stéphane P Ahern; Orla Smith; Faisal Siddiqui; Philippe Jouvet; Kosar Khwaja; Lauralyn McIntyre; Kusum Menon; Jamie Hutchison; David Hornstein; Ari Joffe; Francois Lauzier; Jeffrey Singh; Tim Karachi; Kim Wiebe; Kendiss Olafson; Clare Ramsey; Sat Sharma; Peter Dodek; Maureen Meade; Richard Hall; Robert A Fowler
Journal:  JAMA       Date:  2009-10-12       Impact factor: 56.272

9.  Epidemiology and clinical characteristics of hospitalized patients with pandemic influenza A (H1N1) 2009 infections: the effects of bacterial coinfection.

Authors:  Amreeta Dhanoa; Ngim C Fang; Sharifah S Hassan; Priyatharisni Kaniappan; Ganeswrie Rajasekaram
Journal:  Virol J       Date:  2011-11-03       Impact factor: 4.099

10.  Community-acquired pneumonia due to pandemic A(H1N1)2009 influenzavirus and methicillin resistant Staphylococcus aureus co-infection.

Authors:  Ronan J Murray; James O Robinson; Jodi N White; Frank Hughes; Geoffrey W Coombs; Julie C Pearson; Hui-Leen Tan; Glenys Chidlow; Simon Williams; Keryn J Christiansen; David W Smith
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

View more
  5 in total

1.  Influenza A Virus Reassortment Is Limited by Anatomical Compartmentalization following Coinfection via Distinct Routes.

Authors:  Mathilde Richard; Sander Herfst; Hui Tao; Nathan T Jacobs; Anice C Lowen
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

2.  Discovery of New Ginsenol-Like Compounds with High Antiviral Activity.

Authors:  Aleksandrina S Volobueva; Olga I Yarovaya; Marina V Kireeva; Sophia S Borisevich; Kseniya S Kovaleva; Iliya Ya Mainagashev; Yuri V Gatilov; Margarita G Ilyina; Vladimir V Zarubaev; Nariman F Salakhutdinov
Journal:  Molecules       Date:  2021-11-10       Impact factor: 4.411

3.  Time-Dependent Molecular Motifs of Pulmonary Fibrogenesis in COVID-19.

Authors:  Jan C Kamp; Lavinia Neubert; Maximilian Ackermann; Helge Stark; Christopher Werlein; Jan Fuge; Axel Haverich; Alexandar Tzankov; Konrad Steinestel; Johannes Friemann; Peter Boor; Klaus Junker; Marius M Hoeper; Tobias Welte; Florian Laenger; Mark P Kuehnel; Danny D Jonigk
Journal:  Int J Mol Sci       Date:  2022-01-29       Impact factor: 5.923

Review 4.  Importance of 1918 virus reconstruction to current assessments of pandemic risk.

Authors:  Jessica A Belser; Taronna R Maines; Terrence M Tumpey
Journal:  Virology       Date:  2018-08-22       Impact factor: 3.513

5.  H3N2 Virus as Causative Agent of ARDS Requiring Extracorporeal Membrane Oxygenation Support.

Authors:  Adriano Peris; Giovanni Zagli; Pasquale Bernardo; Massimo Bonacchi; Morena Cozzolino; Lucia Perretta; Alberta Azzi; Giovanni Cianchi
Journal:  Case Rep Med       Date:  2014-01-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.